NCT06000306View on ClinicalTrials.gov

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

CompletedOBSERVATIONAL

Enrollment

192

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

July 31, 2023

Conditions

Measurable Residual Disease

Interventions

DIAGNOSTIC_TEST

Digital Droplet PCR

Measurable residual disease Monitoring by Digital Droplet PCR in the Early Posttransplant Period

Trial Locations (1)

Unknown

The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou

All Listed Sponsors

lead

Zhejiang University

OTHER

NCT06000306 - MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse | Biotech Hunter | Biotech Hunter